That's a very good question Holter49; however, if...
the potential for the drug is as good as we hope/hoped, why haven't any REAL pharma companies stepped forward to try and buy NPHC?
Seems VERY logical that a big pharma company would love to take on NPHC's debt obligations and pay for the trials if there was any REAL potential for the drug applications...
What's $5-10 Million -- or even $20 million -- for a big pharma company? NOTHING!!
So, there's that...
Or... perhaps they would be TERRIFIED of what else Rik could be hiding underneath this company.
As a wise one on this board says:
"Thinking"